IL69544A0 - Benzamide derivatives - Google Patents

Benzamide derivatives

Info

Publication number
IL69544A0
IL69544A0 IL69544A IL6954483A IL69544A0 IL 69544 A0 IL69544 A0 IL 69544A0 IL 69544 A IL69544 A IL 69544A IL 6954483 A IL6954483 A IL 6954483A IL 69544 A0 IL69544 A0 IL 69544A0
Authority
IL
Israel
Prior art keywords
benzamide derivatives
benzamide
derivatives
Prior art date
Application number
IL69544A
Other languages
English (en)
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of IL69544A0 publication Critical patent/IL69544A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL69544A 1982-08-24 1983-08-22 Benzamide derivatives IL69544A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8224296 1982-08-24

Publications (1)

Publication Number Publication Date
IL69544A0 true IL69544A0 (en) 1983-11-30

Family

ID=10532494

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69544A IL69544A0 (en) 1982-08-24 1983-08-22 Benzamide derivatives

Country Status (23)

Country Link
US (1) US4507315A (fr)
JP (1) JPS5955873A (fr)
KR (1) KR840005717A (fr)
AT (1) ATA301083A (fr)
AU (1) AU1818083A (fr)
BE (1) BE897580A (fr)
CA (1) CA1195993A (fr)
CS (1) CS240973B2 (fr)
DE (1) DE3330403A1 (fr)
DK (1) DK386783A (fr)
ES (2) ES525099A0 (fr)
FI (1) FI832989A (fr)
FR (1) FR2532310B1 (fr)
GB (1) GB2126225B (fr)
GR (1) GR78673B (fr)
IL (1) IL69544A0 (fr)
IT (1) IT1169775B (fr)
LU (1) LU84974A1 (fr)
NL (1) NL8302947A (fr)
NO (1) NO833024L (fr)
PT (1) PT77219B (fr)
SE (1) SE8304545L (fr)
ZA (1) ZA836191B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法
US4916145A (en) * 1987-07-10 1990-04-10 Hoffmann-La Roche Inc. Substituted n-[(pyridyl)alkyl]aryl-carboxamide
US4886629A (en) * 1988-06-06 1989-12-12 Allied-Signal Inc. Process for the preparation of fluorinated benzene sulfonyl fluorides
CA2057324A1 (fr) * 1990-12-18 1992-06-19 Lora Louise Fitch Agents hypoglycemiques de type benzamide et sulfonamide
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
EP1196385A1 (fr) * 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated Derives de beta-aminoacide destines au traitement de maladies neurologiques
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
CN101061116A (zh) * 2004-09-24 2007-10-24 詹森药业有限公司 磺酰胺化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349124A (en) * 1957-05-20 1967-10-24 Pfizer & Co C Oral antidiabetic agent
BE756062A (fr) * 1969-09-11 1971-03-11 Boehringer Sohn Ingelheim Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
DK148576A (da) * 1975-04-18 1976-10-19 Boehringer Mannheim Gmbh Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
US4317915A (en) * 1976-08-23 1982-03-02 Hoffmann-La Roche Inc. Novel thiophene derivatives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
US4245120A (en) * 1977-09-27 1981-01-13 American Cyanamid Company 4-(Monoalkylamino)benzene polycarboxylic acids
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
FI832989A0 (fi) 1983-08-22
GB2126225B (en) 1985-10-09
FR2532310A1 (fr) 1984-03-02
ATA301083A (de) 1985-11-15
ES8502691A1 (es) 1985-01-16
ES528012A0 (es) 1985-06-16
BE897580A (fr) 1984-02-23
FI832989A (fi) 1984-02-25
ES525099A0 (es) 1985-01-16
IT1169775B (it) 1987-06-03
GB8322539D0 (en) 1983-09-21
NL8302947A (nl) 1984-03-16
NO833024L (no) 1984-02-24
JPS5955873A (ja) 1984-03-31
US4507315A (en) 1985-03-26
KR840005717A (ko) 1984-11-16
PT77219A (fr) 1983-09-01
CA1195993A (fr) 1985-10-29
ES8505935A1 (es) 1985-06-16
IT8322629A0 (it) 1983-08-24
GB2126225A (en) 1984-03-21
DK386783A (da) 1984-02-25
CS612483A2 (en) 1985-06-13
SE8304545D0 (sv) 1983-08-22
LU84974A1 (fr) 1984-03-23
FR2532310B1 (fr) 1986-01-10
DK386783D0 (da) 1983-08-23
GR78673B (fr) 1984-09-27
SE8304545L (sv) 1984-02-25
ZA836191B (en) 1984-04-25
AU1818083A (en) 1984-03-01
CS240973B2 (en) 1986-03-13
DE3330403A1 (de) 1984-03-01
PT77219B (fr) 1986-02-04

Similar Documents

Publication Publication Date Title
GB8603901D0 (en) Derivatives
GB8328755D0 (en) 3-aryl-5-pyrazole derivatives
GB8300400D0 (en) 5-methylthiopyrimidine derivatives
GB8410727D0 (en) Azet-2-one derivatives
GB2128188B (en) Propynylaminoisoxazole derivatives
EP0096296A3 (en) 1-sulfo-2-oxoazetidine derivatives
GB8321880D0 (en) Desoxyuridine derivatives
GB8329554D0 (en) 7-carboxymethoxyphenylacet-amido-3-cephem derivatives
EP0100250A3 (en) Methylflavone derivatives
GB2132617B (en) Propynlaminothiazole derivatives
GB2126225B (en) Benzamide derivatives
GB8326244D0 (en) Vinylthioacetamido oxacephalosporin derivatives
GB8330016D0 (en) 2-piperazinyl-quinazoline derivatives
GB2123815B (en) Aletheine derivatives
GB8325762D0 (en) Thiatriazine derivatives
GB2131803B (en) Oxacephalosporin derivatives
GB8612237D0 (en) Chleosterol derivatives
GB2135998B (en) Benzamide derivatives
DE3269529D1 (en) Benzamide derivatives
GB2124215B (en) Eburnane-oxime derivatives
GB2121786B (en) 23-demycinosyldesmycosin derivatives
GB2116170B (en) 23-0-acyl-23-demycinosyldesmycosin derivatives
GB8328614D0 (en) Epoxycarbacyclin derivatives
GB8324348D0 (en) 28-methyl-brassino-steroid derivatives
GB8326187D0 (en) 15-cycloaliphatic derivatives